| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acurx Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option | 146K | 05 Feb 2025 | Direct | ||
| Acurx Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option | 145K | 23 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ACXP | Acurx Pharmaceuticals, Inc. | 05 Feb 2025 | 1 | $0 | 4 | Chief Financial Officer | 06 Feb 2025, 17:47 |
| ACXP | Acurx Pharmaceuticals, Inc. | 23 Feb 2024 | 1 | $0 | 4 | Chief Financial Officer | 03 Apr 2024, 21:56 |
| ACXP | Acurx Pharmaceuticals, Inc. | 13 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 24 Feb 2023, 15:32 |
| ACXP | Acurx Pharmaceuticals, Inc. | 29 Jun 2021 | 2 | $0 | 4 | Chief Financial Officer | 06 Jul 2021, 16:06 |
| ACXP | Acurx Pharmaceuticals, Inc. | 24 Jun 2021 | 0 | $0 | 3 | Chief Financial Officer | 24 Jun 2021, 18:22 |